Wound healing is impaired in MyD88-deficient mice: A role for MyD88 in the regulation of wound healing by adenosine A2A receptors

American Journal of Pathology

Volumn 171, Issue 6, 2007, Pages 1774-1788

  Macedo, Lisa ^a   Pinhal Enfield, Grace ^a   Alshits, Vera ^a   Elson, Genie ^a   Cronstein, Bruce Neil ^b   Leibovich, Samuel Joseph ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; EXCISION; GENE EXPRESSION; GRANULATION TISSUE; INFLAMMATION; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN INJURY; WILD TYPE; WOUND CONTRACTION; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 38349014249     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.061048     Document Type: Article

References (98)

1. Leibovich SJ, Ross R: A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol 1976, 84:501-514
2. Leibovich SJ, Ross R: The role of the macrophage in wound repair: a study with hydrocortisone and antimacrophage serum. Am J Pathol 1975, 84:71-85
3. DiPietro LA: Wound healing: the role of the macrophage and other immune cells. Shock 1995, 4:233-240
4. Hume DA, Ross IL, Himes SR, Sasmono RT, Wells CA, Ravasi T: The mononuclear phagocyte system revisited. J Leukoc Biol 2002, 72:621-627
5. Polverini PJ: Macrophage-induced angiogenesis: a review. Cytokines 1989, 1:54-73
6. Fraser I, Doyle A, Hughes D, Gordon S: Use of surface molecules and receptors for studying macrophages and mononuclear phagocytes. J Immunol Methods 1994, 174:95-102
7. Gordon S: Macrophage-restricted molecules: role in differentiation and activation. Immunol Lett 1999, 65:5-8
8. Gordon S, Taylor PR: Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5:953-964
9. Taylor PR, Brown GD, Geldhof AB, Martinez-Pomares L, Gordon S: Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur J Immunol 2003, 33:2090-2097
10. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 2001, 413:732-738
11. Barton GM, Medzhitov R: Toll-like receptors and their ligands. Curr Top Microbiol Immunol 2002, 270:81-92
12. Kaisho T, Akira S: Toll-like receptor function and signaling. J Allergy Clin Immunol 2006, 117:979-987
13. Nicholson AC, Han J, Febbraio M, Silverstein RL, Hajjar DP: Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis. Ann NY Acad Sci 2001, 947:224-228
14. Stahl PD: The mannose receptor and other macrophage lectins. Curr Opin Immunol 1992, 4:49-52
15. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S: Macrophage receptors and immune recognition. Annu Rev Immunol 2005, 23:901-944
16. Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol 2004, 4:499-511
17. Kawai T, Akira S: Toll-like receptor downstream signaling. Arthritis Res Ther 2005, 7:12-19
18. Vogel SN, Fitzgerald KA, Fenton MJ: TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol Interv 2003, 3:466-477
19. Takeuchi O, Hemmi H, Akira S: Interferon response induced by Toll-like receptor signaling. J Endotoxin Res 2004, 10:252-256
20. Takeda K, Akira S: Toll-like receptors in innate immunity. Int Immunol 2005, 17:1-14
21. Ralevic V, Burnstock G: Receptors for purines and pyrimidines. Pharmacol Rev 1998, 50:413-492
22. Traut TW: Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 1994, 140:1-22
23. Feoktistov I, Goldstein AE, Ryzhov S, Zeng D, Belardinelli L, VoynoYasenetskaya T, Biaggioni I: Differential expression of adenosine receptors in human endothelial cells. Circ Res 2002, 90:531-538
24. Phillis JW: Adenosine and adenine nucleotides as regulators of cerebral blood flow: roles of acidosis, cell swelling, and KATP channels. Crit Rev Neurobiol 2004, 16:237-270
25. Feoktistov I, Biaggioni I: Adenosine and endothelial cell function. Edited by Hasko G, Cronstein BN, Szabo C. Boca Raton, CRC Taylor and Francis, 2006, pp 109-130
26. Haskó G, Cronstein BN: Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004, 25:33-39
27. 2a receptor-dependent and independent mechanisms. FASEB J 2000, 14:2065-2074
28. 2A receptors. Am J Pathol 2003, 163:711-721
29. Szabó C, Scott GS, Virag L, Egnaczyk G, Salzman AL, Shanley TP, Hasko G: Suppression of inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists. Br J Pharmacol 1998, 125:379-387
30. 2A receptor agonists and endotoxin. Am J Pathol 2002, 160:2231-2244
31. Ramanathan M, Pinhal-Enfield G, Hao I, Leibovich SJ: Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element (HRE) in the VEGF promoter. Mol Biol Cell 2007, 18:14-23
32. 2A receptors. Am J Pathol 2002, 160:2009-2018
33. Montesinos MC, Shaw JP, Yee H, Shamamian P, Cronstein BN: Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am J Pathol 2004, 164:1887-1892
34. Cronstein BN: Adenosine receptors and wound healing. Sci World J 2004, 4:1-8
35. Gohda J, Matsumura T, Inoue J: Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not Toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling. J Immunol 2004, 173:2913-2917
36. Suzuki N, Suzuki S, Yeh WC: IRAK-4 as the central TIR signaling mediator in innate immunity. Trends Immunol 2002, 23:503-506
37. O'Neill LA: How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 2006, 18:3-9
38. Han J: MyD88 beyond Toll. Nat Immunol 2006, 7:370-371
39. Cronstein BN: Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 1994, 76:5-13
40. Montesinos MC, Gadangi P, Longaker M, Sung J, Levine J, Nilsen D, Reibman J, Li M, Jiang CK, Hirschhorn R, Recht PA, Ostad E, Levin RI, Cronstein BN: Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med 1997, 186:1615-1620
41. Victor-Vega C, Desai A, Montesinos MC, Cronstein BN: Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel). Inflammation 2002, 26:19-24
42. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanashi K, Akira S: Targeted disruption of the MyD88 gene results in loss of IL-1 and IL-18-mediated function. Immunity 1998, 9:143-150
43. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S: Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999, 11:115-122
44. Suzuki N, Suzuki S, Duncan GS, Millar DS, Wada T, Mirtsos C, Takada H, Wakeham A, Itie A, Li S, Penninger JM, Wesche H, Ohashi PS, Mak TW, Yeh WC: Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002, 416:750-754
45. Ramanathan M, Giladi A, Leibovich SJ: Regulation of vascular endothelial growth factor expression in murine macrophages by nitric oxide and hypoxia. Exp Biol Med 2003, 228:697-705
46. Darnay BG, Ni J, Moore PA, Aggarwal BB: Activation of NF-kappa B by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappa B-inducing kinase - identification of a novel TRAF6 interaction motif. J Biol Chem 1999, 274:7724-7731
47. Pollet I, Opina CJ, Zimmerman C, Leong KG, Wong F, Karsan A: Bacterial lipopolysaccharide directly induces angiogenesis through TRAF6-mediated activation of NF-kappaB and c-Jun N-terminal kinase. Blood 2003, 102:1740-1742
48. Kobayashi T, Walsh MC, Choi Y: The role of TRAF6 in signal transduction and the immune response. Microbes Infect 2004, 6:1333-1338
49. Chen ZJ: Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 2005, 7:758-765
50. Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen ZJ: Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000, 103:351-361
51. Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, Morony S, Capparelli C, Van G, Kaufman S, van der Heiden A, Itie A, Wakeham A, Khoo W, Sasaki T, Cao Z, Penninger JM, Paige CJ, Lacey DL, Dunstan CR, Boyle WJ, Goeddel DV, Mak TW: TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 1999, 13:1015-1024
52. Naito A, Yoshida H, Nishioka E, Satoh M, Azuma S, Yamamoto T, Nishikawa S, Inoue J: TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc Natl Acad Sci USA 2002, 99:8766-8771
53. Creagh EM, O'Neill LA: TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 2006, 27:352-357
54. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S: Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003, 301:640-643
55. Jiang Z, Mak TW, Sen G, Li X: Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta. Proc Natl Acad Sci USA 2004, 101:3533-3538
56. Hasko G, Szabo C: Regulation of monocyte/macrophage function by adenosine receptors. Edited by Hasko G, Cronstein BN, Szabo C. Boca Raton, CRC Taylor and Francis, 2006, pp 49-68
57. Nemeth ZH, Leibovich SJ, Deitch EA, Vizi ES, Szabo C, Hasko G: cDNA microarray analysis reveals a nuclear factor-κB-independent regulation of macrophage function by adenosine. J Pharmacol Exp Ther 2003, 306:1042-1049
58. Rawlings DJ: The biology and biochemistry of inflammatory signalosomes. Meeting on signaling networks in immunity and inflammation. EMBO Rep 2006, 7:25-30
59. Kishida S, Sanjo H, Akira S, Matsumoto K, Ninomiya-Tsuji J: TAK1-binding protein 2 facilitates ubiquitination of TRAF6 and assembly of TRAF6 with IKK in the IL-1 signaling pathway. Genes Cells 2005, 10:447-454
60. Leibovich SJ: Regulation of macrophage-dependent angiogenesis by adenosine and Toll-like receptors. Edited by Hasko G, Cronstein BN, Szabo C. Boca Raton, CRC Taylor and Francis, 2006, pp 325-346
61. Wang Y, Tang Y, Teng L, Wu Y, Zhao X, Pei G: Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 2006, 7:139-147
62. Feng CG, Scanga CA, Collazo-Custodio CM, Cheever AW, Hieny S, Caspar P, Sher A: Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J Immunol 2003, 171:4758-4764
63. Seki E, Tsutsui H, Tsuji NM, Hayashi N, Adachi K, Nakano H, Futatsugi-Yumikura S, Takeuchi O, Hoshino K, Akira S, Fujimoto J, Nakanishi K: Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J Immunol 2002, 169:3863-3868
64. Björkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, Means T, Halmen K, Luster AD, Golenbock DT, Freeman MW: Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 2004, 10:416-421
65. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M: Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004, 101:10679-10684
66. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R: Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241
67. Pull SL, Doherty JM, Mills JC, Gordon JI, Stappenbeck TS: Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci USA 2005, 102:99-104
68. Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissmann G: Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 1992, 148:2201-2206
69. Cronstein BN, Rosenstein ED, Kramer SB, Weissmann G, Hirschhorn R: Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol 1985, 135:1352-1366
70. Revan S, Montesinos MC, Naime D, Landau S, Cronstein BN: Adenosine A2 receptor occupancy regulates stimulated neutrophil function via activation of a serine/threonine protein phosphatase. J Biol Chem 1996, 271:17114-17118
71. Khoa ND, Postow M, Danielsson J, Cronstein BN: Tumor necrosis factor-alpha prevents desensitization of Galphas-coupled receptors by regulating GRK2 association with the plasma membrane. Mol Pharmacol 2006, 69:1311-1319
72. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23:549-555
73. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35
74. Deepak P, Kumar S, Acharya A: Interleukin-13-induced type II polarization of inflammatory macrophages is mediated through suppression of nuclear factor-kappaB and preservation of IkappaBalpha in a T cell lymphoma. Clin Exp Immunol 2007, 149:378-386
75. Guo JJ, Su FX, Yao HR, Chen JS: Alternatively activated macrophages/mononuclear phagocytes promote growth and invasion of breast cancer cell line SKBR3. Nan Fang Yi Ke Da Xue Xue Bao 2007, 27:410-413
76. Kahnert A, Seiler P, Stein M, Bandermann S, Hahnke K, Mollenkopf H, Kaufmann SH: Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. Eur J Immunol 2006, 36:631-647
77. Porcheray F, Viaud S, Rimaniol AC, Leone C, Samah B, Dereuddre-Bosquet N, Dormont D, Gras G: Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 2005, 142:481-489
78. Van Ginderachter JA, Movahedi K, Hassanzadeh Ghassabeh G, Meerschaut S, Beschin A, Raes G, De Baetselier P: Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology 2006, 211:487-501
79. Leibovich SJ: Macrophages, Adenosine and Toll-Like Receptors: Their Role in the Regulation of Atherosclerotic Lesion Development. Edited by Reiss AB, Carsons S, and Cronstein BN. Kerala, Research Signpost, 2006, pp 35-62
80. Adair TH: An emerging role for adenosine in angiogenesis. Hypertension 2004, 44:618-620
81. Burnstock G: Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 2002, 22:364-373
82. Keddie JR, Poucher SM, Shaw GR, Brooks R, Collis MG: In vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist. Eur J Pharmacol 1996, 301:107-113
83. Murphree LJ, Sullivan GW, Marshall MA, Linden J: Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction. Biochem J 2005, 391:575-580
84. Khoa ND, Montensinos MK, Reiss AB, Delano D, Awadallah N, Cronstein BN: Inflammatory cytokines regulate function and expression of adenosine A2A receptors in human monocytic THP-1 cells. J Immunol 2001, 167:4026-4032
85. Hultmark D: Macrophage differentiation marker Myd88 is a member of the Toll/IL-1 receptor family. Biochem Biophys Res Commun 1994, 199:144-146
86. Mertz PM, Sauder DL, Davis SC, Kilian PL, Herron AJ, Eaglstein WH: IL-1 as a potent inducer of wound reepithelialization. Prog Clin Biol Res 1991, 365:473-480
87. Liu W, Ding I, Chen K, Olschowka J, Xu J, Hu D, Morrow GR, Okunieff P: Interleukin 1beta (IL1B) signaling is a critical component of radiation-induced skin fibrosis. Radiat Res 2006, 165:181-191
88. Ishida Y, Kondo T, Kimura A, Matsushima K, Mukaida N: Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappaB activation and a reciprocal suppression of TGF-beta signal pathway. J Immunol 2006, 176:5598-5606
89. Bettinger DA, Pellicane JV, Tarry WC, Yager DR, Diegelmann RF, Lee R, Cohen IK, DeMaria EJ: The role of inflammatory cytokines in wound healing: accelerated healing in endotoxin-resistant mice. J Trauma 1994, 36:810-813
90. Janssens S, Beyaert R: A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem Sci 2002, 27:474-482
91. Chen Q, Carroll HP, Gadina M: The newest interleukins: recent additions to the ever-growing cytokine family. Vitam Horm 2006, 74:207-228
92. Dinarello CA: An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor. Immunity 2005, 23:461-462
93. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490
94. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, Medzhitov R, Noble PW: Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005, 11:1173-1179
95. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI: Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920
96. Gordon JI: A genomic view of our symbiosis with members of the gut microbiota. J Pediatr Gastroenterol Nutr 2005, 40(Suppl 1):S28
97. Xu J, Gordon JI: Inaugural article: honor thy symbionts. Proc Natl Acad Sci USA 2003, 100:10452-10459
98. Beg AA: Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 2002, 23:509-512